期刊文献+

原发性醛固酮增多症23例临床分析 被引量:2

在线阅读 下载PDF
导出
摘要 原发性醛固酮增多症(primary aldosteronism,PA)是由肾上腺皮质分泌过多的醛固酮而引起的高血压、低血钾、肌无力、高醛固酮及低肾素活性为主要特征的综合征。Conn于1955年首先指出肾上腺皮质腺瘤分泌过多的醛固酮是本病的原因,
出处 《疑难病杂志》 CAS 2010年第8期621-622,共2页 Chinese Journal of Difficult and Complicated Cases
  • 相关文献

参考文献9

  • 1孙宁玲.原发性醛固酮增多性高血压的筛查[N].中国医学论坛报,2008-07-24(3).
  • 2Kaplan NM.The current epdemic of primary aldosteronism:causes and consequences[J].J Hpertension,2004,22(5):863-869.
  • 3Rossi E,Regolisti G,Negro A,et al.Highpervalence of primary aldosteronisum using postcaptopril plasma aldosterone to rennin ratio as a screening test among Italian hypertensives[J].J Clin Endocrinol Metab,2000,85(12):4526-4533.
  • 4Milliez P,Girerd X,Plouin PF.Evidence for an increased rate of cardiovascularevents in patients with primary aldosteronism[J].J Am Coll Cardiol,2005,45(8):1243-1248.
  • 5Funder JW,Carey RM,Fardella C,et ai.Case detection,diagnosis,and treatment of patients with primary aldosteronism:an endocrine society clinical practice guideline[J].J Clin Endocrinol Metab,2008,93(9):3266-3281.
  • 6周晓峰(综述),鲍镇美(审校).原发性醛固酮增多症的新认识[J].国际泌尿系统杂志,2007,27(2):195-198. 被引量:7
  • 7李志立,刘凡,张伟,杨欣国,赵连友,金葵花,吴学勤.原发性醛固酮增多症35例的诊治分析[J].中华高血压杂志,2007,15(2):155-156. 被引量:7
  • 8朱鼎良.应重视在高血压患者中开展原发性醛固酮增多症的筛查、确诊和分型定位检查[J].中华心血管病杂志,2006,34(10):865-867. 被引量:8
  • 9Letavernier E,Peyrard S,Amar L,et al.Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenoma[J].J Hypertens,2008,26(9):1816-1823.

二级参考文献36

  • 1陈绍行,杜月凌,张瑾,龚艳春,胡亚蓉,初少莉,何清波,宋艳艳,朱鼎良.在高血压患者中筛选原发性醛固酮增多症国人血浆醛固酮/肾素活性比值标准的探讨[J].中华心血管病杂志,2006,34(10):868-872. 被引量:48
  • 2张惠兰,刘振江,邵娇梅,严江涛,汪道文.血浆醛固酮/肾素活性比值在诊断原发性醛固酮增多症患者的价值[J].中华心血管病杂志,2006,34(10):873-876. 被引量:17
  • 3[2]Edited by Braunwald E.Heart disease[M].Beijing:Science press Harcourt Asia,1999:829.
  • 4Loh KC,Koay ES,Khaw MC,et al.Prevalence of primary aldosteronism among Asia hypertensive patients in Singapore.J Clin Endocrinol Metab,2000,85:2854-2859.
  • 5Calhoun DA,Nishizaka MK,Zaman MA,et al.Hyperaldosteronism among black and white subjects with resistant hypertension.Hypertension,2002,40:892-896.
  • 6Mosso L,Carvajal C,Gonzalez A,et al.Primary aldosteronism and hypertensive disease.Hypertension,2003,42:161-165.
  • 7Hiramatsu K,Yamada T,Yukimura Y,et al.A screening test to identify aldosterone-producing adenoma by measuring plasma rennin activity.Results in hypertensive patients.Arch Intern Med,1981,141:1589-1593.
  • 8Kaplan NM.The current epidemic of primary aldosteronism:causes and consequences.J Hypertens,2004,22:863-869.
  • 9Mulatero P,Stowasser M,Loh KC,et al.Increased diagnosis of primary aldosteronism,including surgically correctable forms,in centers from five continents.J Clin Endocrinol Metab,2004,89:1045-1050.
  • 10Stowasser M,Gordon RD,Gunasekera TG,et al.High rate of detection of primary aldosteronism,including surgically treatable forms,after "non-selective" screening of hypertensive patients.J Hypertens,2003,21:2149-2157.

共引文献19

同被引文献21

  • 1韩书宏,黎世坤,孙杰,黄镇,陈亚想.原发性醛固酮增多症16例临床分析[J].中国医药导报,2007,4(04Z):26-27. 被引量:1
  • 2Stowasser M. Update in primary aldosteronism [ J 1. J Clin Endocrinol Metab ,2009,94(10) :3623-3630.
  • 3Kaplan NM. Primary aldosteronism: evidence against a second epidem- ic[ J]. J Hypertens, 2012,30(10) :1899-1902.
  • 4blosso L, Carvajal C, Gonzolez A, et al. Primary aldosteronism and hy- pertensive disease [ J ]. Hypertension, 2003,42 ( 2 ) : 161-165.
  • 5Conn JW, Cohen EL, Rovner DR, et al. Normokalemic primary aldoste- ronism a detectable cause of curable essential hypertenston [ J ]. JAMA, 1965,193:200-206.
  • 6Hannemann A, Bidlingmaier M, Friedrich N, et al. Screening for prima- ry aldosteronism in hypertensive subjects: results from two German epi- demiological studies[ J]. Eur J Endocrinol, 2012,167 ( 1 ) :7-15.
  • 7PotthoffS A, Beuschlein F, Vonend O. Primay hyperaldosteronism-diag- nostic and treatment [ J ]. Dtsch Med Wochenschr, 2012, 137 ( 48 ) : 2480-2484.
  • 8Acelajado MC, Calhoun DA. Aldosteronism and resitant hypeitension [J]. Int J Hypertens,2011,20( 1 ) :817-820.
  • 9Born-Frontsberg E, Reincke M, Rump LC, et al. Cardiovascular and ce- rebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn's Registry[ J]. Clin Endocri- nol Metab ,2009,94 (4) : 1125-1130.
  • 10Acelajado MC, Calhoun DA. Aldosteronism and resitant hypeitension [ J ]. Int J Hypertens,2011,20 ( 1 ) : 817 -820.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部